Triozzi, P L <br/><br/>
Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma.  [electronic resource] 

 -  Cancer investigation  1996 
 - 293-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-7907 
<br/><br/><label>Standard No.: </label>10.3109/07357909609012154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2',5'-Oligoadenylate Synthetase--biosynthesis<br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Isotretinoin--adverse effects<br/>Killer Cells, Natural--immunology<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Male<br/>Melanoma--pathology<br/>Middle Aged<br/>Necrosis<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Recombinant Proteins<br/>Skin Neoplasms--pathology